IQVIA Holdings Inc. (IQV)
Helps pharmaceutical companies run clinical trials and understand healthcare market data.
$213.22+0.02%Healthcare
StockGlow Score
Bullish
BearishBullish
1 year ago+16.9%
The outlook
IQV trades at $213.22 with analyst sentiment strongly bullish (average rating 1.5/5), and the stock sits above both its 50- and 200-day moving averages. Currently positioned about 63% of the way through its 52-week range, the average analyst price target sits roughly 9% above the current price.
What’s behind the score
Analyst consensusStrong Buy — 1.5 avg of 19 analysts
Price trendAbove its 50- & 200-day averages
52-week range63% of the way from its 52-week low to high
Price targetAvg target +9% vs current price
Analyst price target
~12-month · 19 analysts$232.00average target+8.8% vs now
Now $213.22
Low $200.00High $284.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$35.59B
52-wk high
$247.05
52-wk low
$154.50
50-day avg
$187.58
200-day avg
$196.60
Trailing P/E
25.8